Forbes June 5, 2023
Robert Hart

Topline

Neuralink, Elon Musk’s brain implant company, has won approval from the Food and Drug Administration to start testing its device in humans, one of a growing cadre of neurotech pioneers with goals of merging humans with machines to treat a range of medical conditions such as paralysis, blindness and depression—and enhance existing abilities like memory or allow us to interact with computers by thought alone.

Key Facts

News Peg

In late May, Neuralink announced it had secured FDA approval to launch its first “in-human clinical study.” The decision “represents an important first step that will one day allow our technology to help many people,” the firm said, adding that it was the result of “incredible work” by the Neuralink...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Patient / Consumer, Provider, Technology
ChatGPT outperformed doctors again? Pitfalls of reporting AI progress
Patient Portals 4.0: Future of Patient Engagement
AI tool could predict type 2 diabetes 10 years in advance
Google digs deeper into healthcare AI: 5 notes
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?

Share This Article